The Pharmaceutical Lipid-Based Excipients Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The pharmaceutical lipid-based excipients market witnessed significant growth recently. The market size was $1.69 billion in 2024, and it will increase to $1.79 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 5.8%.
The pharmaceutical lipid-based excipients market is forecasted to reach $2.22 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.5%.
Download Your Free Sample of the 2025 Pharmaceutical Lipid-Based Excipients Market Report and Uncover Key Trends Now!The key drivers in the pharmaceutical lipid-based excipients market are:
• Rising demand for advanced drug delivery systems
• Expanding pipeline of poorly water-soluble drugs and corresponding solubility solutions
• Increased adoption of personalized medicine, mRNA, and gene therapies
• Strategic investments in biopharmaceutical manufacturing infrastructure and scalability
The pharmaceutical lipid-based excipients market covered in this report is segmented –
1) By Excipient Type: Oils, Hydrogenated Vegetable Oils, GMCC, Hard Fats, Medium Chain Triglycerides, Lecithin And Phospholipids, Sodium Oleate, Capri Caprylic Mono Diglyceride, Other Excipient Types
2) By Product Applications: Oral Formulations, Parenteral, Topical Applications, Ophthalmic Applications, Suppositories, Other Product Applications
3) By Disease Application: Cardiovascular Diseases, Neurological Disorders, Oncology, Metabolic Disorders, Hormonal Therapies, Infectious Diseases, Other Disease Applications
4) By Age Group: Pediatric Products (0-18 years), Adult Products (19-64 years), Geriatric Products (65+ years)
5) By End-Use: Pharmaceutical Manufacturers, Contract Development And Manufacturing Organizations, Other End Users
The key trends in the pharmaceutical lipid-based excipients market are:
• Innovations in lipid nanoparticle delivery systems are becoming a prevalent trend.
• Adoption of mRNA and gene therapies is increasingly influencing the market.
• There's a trend of providing improved solubility solutions for poorly water-soluble drugs.
• The expansion of biocompatible and sustainable lipid sources is emerging as a significant trend.
Major players in the pharmaceutical lipid-based excipients market are:
• Cargill Incorporated
• BASF SE
• Merck KGaA
• FUJIFILM Corporation
• Evonik Industries AG
• DuPont de Nemours Inc.
• Stepan Company
• Croda International
• Ashland Corporation
• NOF CORPORATION
• CordenPharma
• SEPPIC
• Nippon Fine Chemical Co. Ltd.
• Cayman Chemical
• ABITEC Corporation
• Creative Biolabs
• IOI Oleo GmbH
• Lipoid
• RuixiBiotechCo.Ltd
• Biosynth
Europe was the largest region in the pharmaceutical lipid-based excipients market in 2024